Impact of Cangrelor on Coronary Thrombus: Optical Coherence Tomography Assessment

Cardiovasc Revasc Med. 2020 May;21(5):700-701. doi: 10.1016/j.carrev.2020.01.021. Epub 2020 Jan 30.

Authors

Evan Shlofmitz¹, Hector M Garcia-Garcia¹, Gebremedhin D Melaku¹, Susan V Thomas², Rebecca Torguson¹, Howard Sacher², Allen Jeremias², Richard Shlofmitz², Ron Waksman³

Affiliations

¹ Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, DC, USA.
² Department of Cardiology, St. Francis Hospital - The Heart Center, Roslyn, NY, USA.
³ Section of Interventional Cardiology, MedStar Washington Hospital Center, Washington, DC, USA. Electronic address: [email protected].

PMID: 32033895
DOI: 10.1016/j.carrev.2020.01.021

No abstract available

Keywords: Cangrelor; Optical coherence tomography; Percutaneous coronary intervention; Thrombus.

Publication types

Case Reports

MeSH terms

Adenosine Monophosphate / analogs & derivatives*
Adenosine Monophosphate / therapeutic use
Angioplasty, Balloon, Coronary* / instrumentation
Coronary Angiography
Coronary Thrombosis / diagnostic imaging
Coronary Thrombosis / therapy*
Drug-Eluting Stents
Humans
Male
Middle Aged
Non-ST Elevated Myocardial Infarction / diagnostic imaging
Non-ST Elevated Myocardial Infarction / therapy*
Platelet Aggregation Inhibitors / therapeutic use*
Predictive Value of Tests
Tomography, Optical Coherence*
Treatment Outcome

Substances

Platelet Aggregation Inhibitors
Adenosine Monophosphate
cangrelor